Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01526291 · ClinicalTrials.gov registry record
Patient-Reported Outcomes With LASIK:PROWL-1
A clinical trial, sponsored by Food and Drug Administration (FDA).
- Completed
- Registry status
- 550
- Enrollment target
NCT01526291: Completed study, sponsored by Food and Drug Administration (FDA).
NCT01526291 is a clinical trial that has completed, run by Food and Drug Administration (FDA). The registered enrollment target is 550 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01526291 has completed, sponsored by Food and Drug Administration (FDA).
- COMPLETED
- Registry status
- 550 participants
- Enrollment target
Study Summary
This study evaluates a questionnaire designed to measure satisfaction and ophthalmic-related quality of life (QOL)in up to 550 active duty subjects prior to and six months following state-of-the-art laser in situ keratomileusis (LASIK).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2011-08 |
What the finished NCT01526291 record still lists
NCT01526291 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01526291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01526291 about?
NCT01526291 is a clinical study titled "Patient-Reported Outcomes With LASIK:PROWL-1". This study evaluates a questionnaire designed to measure satisfaction and ophthalmic-related quality of life (QOL)in up to 550 active duty subjects prior to and six months following state-of-the-art laser in situ keratomileusis (LASIK).
What is the current status of trial NCT01526291?
This trial is currently completed. The enrollment target is 550 participants. The study started on 2011-08.
Who is sponsoring clinical trial NCT01526291?
This trial is sponsored by Food and Drug Administration (FDA), which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia